Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects

NCT05907382 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability

Interventions

DRUG: JMKX003002 will be administered orally
DRUG: JMKX003002 will be administered orally
DRUG: JMKX003002 will be administered orally
DRUG: Placebo in Cohorts 1 to 5
DRUG: Placebo in 2 Cohorts

Sponsor

Jemincare